| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |